News

Qilu Pharmaceutical Ranked No. 9 among Top 100 Chinese Pharmaceutical Companies

ABOUT US

News

Qilu Pharmaceutical Ranked No. 9 among Top 100 Chinese Pharmaceutical Companies

Release time：

2021-08-01

The 38^th Pharmaceutical Industry Information Annual Conference hosted by China National Pharmaceutical Industry Information Center was inaugurated on August 1^st, 2021.

The list of the Top 100 Chinese Pharmaceutical Companies was released and Qilu pharmaceutical ranked No. 9. The company was also awarded as The Best R&D Pipeline Pharmaceutical Company at the event and ranked No. 2 in the year of 2021.

Qilu Pharmaceutical Awarded as the Best R&D Pipeline Pharmaceutical Company

Qilu Pharmaceutical Acquired an Exclusive Right for the Development and Commercialization of Vicineum™ in Greater China

Related News

Qilu Pharmaceutical ranks No.3 in the list of "Top 100 Enterprises in Chinese Pharmaceutical industry”

2024-09-30

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”